
Australians are at risk of wasting hundreds of dollars on intravenous infusion "cocktails" marketed with dodgy and misleading promises, the medical regulator warns.
The Australian Health Practitioner Regulation Agency has this week put several businesses on notice, warning their marketing tactics for intravenous infusion treatments may be against national law.